{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:08:00Z","timestamp":1791338880520,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP21\/00015 and PID2021-123054OB-I00"],"award-info":[{"award-number":["PMP21\/00015 and PID2021-123054OB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Estela Matutes Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01146-z","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T16:02:02Z","timestamp":1727107322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Ece","family":"\u00d6zo\u011ful","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-4252","authenticated-orcid":false,"given":"Melina","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-6456","authenticated-orcid":false,"given":"Gerard","family":"Frigola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Balagu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Syrykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-008X","authenticated-orcid":false,"given":"Pablo","family":"Bousquets-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-3326","authenticated-orcid":false,"given":"Marco M.","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-9845","authenticated-orcid":false,"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Carras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Valmary-Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-516X","authenticated-orcid":false,"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bosch-Schips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7092-9160","authenticated-orcid":false,"given":"Julia","family":"Salmeron-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ruiz-Gasp\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-9822","authenticated-orcid":false,"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0301","authenticated-orcid":false,"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-1483","authenticated-orcid":false,"given":"Xose S.","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","volume":"131","author":"XA Puente","year":"2018","unstructured":"Puente XA, Jares P, Campo E. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood. 2018;131:2283\u201329.","journal-title":"Blood"},{"key":"1146_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","volume":"61","author":"SC Hsiao","year":"2012","unstructured":"Hsiao SC, Cortada IR, Colomo L, Ye H, Liu H, Kuo SY, et al. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Histopathology. 2012;61:685\u201393.","journal-title":"Histopathology"},{"key":"1146_CR3","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/cncr.28664","volume":"120","author":"CY Ok","year":"2014","unstructured":"Ok CY, Xu-Monette ZY, Tzankov A, O\u2019Malley DP, Montes-Moreno S, Visco C, et al. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer. 2014;120:1818\u201329.","journal-title":"Cancer"},{"key":"1146_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/ejh.12119","volume":"91","author":"Y Nishida","year":"2013","unstructured":"Nishida Y, Takeuchi K, Tsuda K, Ugai T, Sugihara H, Yamakura M, et al. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12. Eur J Haematol. 2013;91:179\u201382.","journal-title":"Eur J Haematol"},{"key":"1146_CR5","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3109\/10428194.2016.1153085","volume":"57","author":"I Schliemann","year":"2016","unstructured":"Schliemann I, Oschlies I, Nagel I, Murga Penas EM, Siebert R, Sander B. The t(11;14)(q13;q32)\/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia. Leuk Lymphoma. 2016;57:2672\u20136.","journal-title":"Leuk Lymphoma"},{"key":"1146_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cancergen.2015.03.007","volume":"208","author":"PR Koduru","year":"2015","unstructured":"Koduru PR, Chen W, Garcia R, Fuda F. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2). Cancer Genet 2015;208:303\u20139.","journal-title":"Cancer Genet"},{"key":"1146_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1309\/42CQ0HU7XEY9QMQX","volume":"129","author":"M Ehinger","year":"2008","unstructured":"Ehinger M, Linderoth J, Christensson B, Sander B, Cavallin-Stahl E. A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus. Am J Clin Pathol. 2008;129:630\u20138.","journal-title":"Am J Clin Pathol"},{"key":"1146_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/PAS.0000000000000120","volume":"38","author":"D Juskevicius","year":"2014","unstructured":"Juskevicius D, Ruiz C, Dirnhofer S, Tzankov A. Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements. Am J Surg Pathol. 2014;38:719\u201327.","journal-title":"Am J Surg Pathol"},{"key":"1146_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1309\/AJCPUIDW2CPTA1JA","volume":"143","author":"M Al-Kawaaz","year":"2015","unstructured":"Al-Kawaaz M, Mathew S, Liu Y, Gomez ML, Chaviano F, Knowles DM, et al. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. Am J Clin Pathol. 2015;143:288\u201399.","journal-title":"Am J Clin Pathol"},{"key":"1146_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/pin.12335","volume":"65","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Ichikawa A, Miyoshi H, Kiyasu J, Kimura Y, Arakawa F, et al. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements. Pathol Int. 2015;65:519\u201327.","journal-title":"Pathol Int"},{"key":"1146_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/hon.2779","volume":"38","author":"AM Parrott","year":"2020","unstructured":"Parrott AM, Haggiagi AM, Murty VV, Bhagat G, Alobeid B. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma? Hematol Oncol. 2020;38:817\u201322.","journal-title":"Hematol Oncol"},{"key":"1146_CR12","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1097\/HS9.0000000000000505","volume":"5","author":"J Cheng","year":"2021","unstructured":"Cheng J, Hashem MA, Barabe F, Cloutier S, Xi L, Raffeld M, et al. CCND1 genomic rearrangement as a secondary event in high grade B-cell lymphoma. Hemasphere. 2021;5:e505.","journal-title":"Hemasphere"},{"key":"1146_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/bjh.18697","volume":"201","author":"MR Wilson","year":"2023","unstructured":"Wilson MR, Barrett A, Cheah CY, Eyre TA. How I manage mantle cell lymphoma: indolent versus aggressive disease. Br J Haematol. 2023;201:185\u201398.","journal-title":"Br J Haematol"},{"key":"1146_CR14","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1182\/bloodadvances.2023010757","volume":"7","author":"JN Gerson","year":"2023","unstructured":"Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, et al. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Adv. 2023;7:7393\u2013401.","journal-title":"Blood Adv"},{"key":"1146_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/PAS.0000000000001233","volume":"43","author":"J Xu","year":"2019","unstructured":"Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, et al. SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients. Am J Surg Pathol. 2019;43:710\u201316.","journal-title":"Am J Surg Pathol"},{"key":"1146_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/blood-2018-03-838136","volume":"132","author":"G Clot","year":"2018","unstructured":"Clot G, Jares P, Gine E, Navarro A, Royo C, Pinyol M, et al. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood. 2018;132:413\u201322.","journal-title":"Blood"},{"key":"1146_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, D\u00edaz-Navarro A, Duran-Ferrer M, Navarro A, et al. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020;136:1419\u201332.","journal-title":"Blood"},{"key":"1146_CR18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","volume":"28","author":"F Nadeu","year":"2022","unstructured":"Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022;28:1662\u201371.","journal-title":"Nat Med"},{"key":"1146_CR19","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea S, Valdes-Mas R, Navarro A, Salaverria I, Mart\u00edn-Garcia D, Jares P, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA. 2013;110:18250\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1146_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood.2019002385","volume":"136","author":"P Pararajalingam","year":"2020","unstructured":"Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, et al. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020;136:572\u201384.","journal-title":"Blood"},{"key":"1146_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153283","volume":"132","author":"S Yi","year":"2022","unstructured":"Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, et al. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. J Clin Invest. 2022;132:e153283.","journal-title":"J Clin Invest"},{"key":"1146_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37:551\u201368.","journal-title":"Cancer Cell"},{"key":"1146_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"key":"1146_CR24","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy SE, Barrans SL, Beer PA, Painter D, Smith AG, Roman E, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 2020;135:1759\u201371.","journal-title":"Blood"},{"key":"1146_CR25","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L de Leval","year":"2022","unstructured":"de Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies A, Dogan A, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140:2193\u201327.","journal-title":"Blood"},{"key":"1146_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/hon.3132","volume":"41","author":"P Mozas","year":"2023","unstructured":"Mozas P, Lopez C, Grau M, Nadeu F, Clot G, Valle S, et al. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors. Hematol Oncol. 2023;41:631\u201343.","journal-title":"Hematol Oncol"},{"key":"1146_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17095-7","volume":"11","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Mas-de-Les-Valls R, Navarro A, Royo R, Mart\u00edn S, Villamor N, et al. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms. Nat Commun. 2020;11:3390.","journal-title":"Nat Commun"},{"key":"1146_CR28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-15-1170","volume":"22","author":"V Bikos","year":"2016","unstructured":"Bikos V, Karypidou M, Stalika E, Baliakas P, Xochelli A, Sutton LA, et al. An immunogenetic signature of ongoing antigen interactions in splenic marginal zone lymphoma expressing IGHV1-2*04 receptors. Clin Cancer Res. 2016;22:2032\u201340.","journal-title":"Clin Cancer Res"},{"key":"1146_CR29","first-page":"470","volume":"90","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 2005;90:470\u20138.","journal-title":"Haematologica"},{"key":"1146_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1158\/1078-0432.CCR-20-2558","volume":"27","author":"A Rivas-Delgado","year":"2021","unstructured":"Rivas-Delgado A, Nadeu F, Enjuanes A, Casanueva-Eliceiry S, Mozas P, Magnano L, et al. Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study. Clin Cancer Res. 2021;27:513\u201321.","journal-title":"Clin Cancer Res"},{"key":"1146_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqad056","volume":"5","author":"A Diaz-Navarro","year":"2023","unstructured":"Diaz-Navarro A, Bousquets-Munoz P, Nadeu F, L\u00f3pez-Tamargo S, Be\u00e0 S, Campo E, et al. RFcaller: a machine learning approach combined with read-level features to detect somatic mutations. NAR Genom Bioinform. 2023;5:lqad056.","journal-title":"NAR Genom Bioinform"},{"key":"1146_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ng.2583","volume":"45","author":"N Weinhold","year":"2013","unstructured":"Weinhold N, Johnson DC, Chubb D, Chen B, F\u00f6rsti A, Hosking FJ, et al. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet. 2013;45:522\u201325.","journal-title":"Nat Genet"},{"key":"1146_CR33","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","volume":"35","author":"D Hubschmann","year":"2021","unstructured":"Hubschmann D, Kleinheinz K, Wagener R, Bernhart SH, L\u00f3pez C, Toprak UH, et al. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021;35:2002\u201316.","journal-title":"Leukemia"},{"key":"1146_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2023.101513","volume":"36","author":"M Grau","year":"2023","unstructured":"Grau M, Lopez C, Martin-Subero JI, Bea S. Cytogenomics of B-cell non-Hodgkin lymphomas: the \u201cold\u201d meets the \u201cnew. Best Pract Res Clin Haematol. 2023;36:101513.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1146_CR35","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","volume":"6","author":"L Frauenfeld","year":"2022","unstructured":"Frauenfeld L, Castrejon-de-Anta N, Ramis-Zaldivar JE, Streich S, Salmer\u00f3n-Villalobos J, Otto F, et al. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. Blood Adv. 2022;6:2361\u201372.","journal-title":"Blood Adv"},{"key":"1146_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2019002699","volume":"135","author":"JE Ramis-Zaldivar","year":"2020","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farre B, Balague O, Celis V, Nadeu F, Salmer\u00f3n-Villalobos J, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020;135:274\u201386.","journal-title":"Blood"},{"key":"1146_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2021012386","volume":"139","author":"F Bonfiglio","year":"2022","unstructured":"Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, et al. Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood. 2022;139:732\u201347.","journal-title":"Blood"},{"key":"1146_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","volume":"32","author":"K Karube","year":"2018","unstructured":"Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia. 2018;32:675\u201384.","journal-title":"Leukemia"},{"key":"1146_CR39","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/bjh.18994","volume":"203","author":"ED Carlsen","year":"2023","unstructured":"Carlsen ED, Aarabi M, Swerdlow SH. Unexpected MYC::DMD translocation after transformation of follicular lymphoma with IGH::BCL2 and IGH::MYC. Br J Haematol. 2023;203:e74\u2013e77.","journal-title":"Br J Haematol"},{"key":"1146_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","volume":"28","author":"FI Camacho","year":"2004","unstructured":"Camacho FI, Garcia JF, Cigudosa JC, Mollejo M, Algara P, Ru\u00edz-Ballesteros E, et al. Aberrant Bcl6 protein expression in mantle cell lymphoma. Am J Surg Pathol. 2004;28:1051\u20136.","journal-title":"Am J Surg Pathol"},{"key":"1146_CR41","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1182\/bloodadvances.2023011763","volume":"8","author":"C Lopez","year":"2024","unstructured":"Lopez C, Silkenstedt E, Dreyling M, Bea S. Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma. Blood Adv. 2024;8:3652\u20133664.","journal-title":"Blood Adv"},{"key":"1146_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature18294","volume":"534","author":"K Kataoka","year":"2016","unstructured":"Kataoka K, Shiraishi Y, Takeda Y, Sakata S, Matsumoto M, Nagano S, et al. Aberrant PD-L1 expression through 3\u2019-UTR disruption in multiple cancers. Nature. 2016;534:402\u20136.","journal-title":"Nature"},{"key":"1146_CR43","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","volume":"4","author":"HA Hill","year":"2020","unstructured":"Hill HA, Qi X, Jain P, Nomie K, Wang Y, Zhou S, et al. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. Blood Adv. 2020;4:2927\u201338.","journal-title":"Blood Adv"},{"key":"1146_CR44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3324\/haematol.2019.219543","volume":"105","author":"B Federmann","year":"2020","unstructured":"Federmann B, Frauenfeld L, Pertsch H, Borgmann V, Steinhilber J, Bonzheim I, et al. Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression. Haematologica. 2020;105:754\u201364.","journal-title":"Haematologica"},{"key":"1146_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C Lopez","year":"2019","unstructured":"Lopez C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, H\u00fcbschmann D, et al. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun. 2019;10:1459.","journal-title":"Nat Commun"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01146-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T16:02:05Z","timestamp":1727107325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01146-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01146-z","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.N. received honoraria from Janssen, AbbVie, AstraZeneca, and SOPHiA GENETICS for speaking in educational activities, and research funding from Gilead. E.C. has been a consultant for Takeda; has received honoraria from Janssen, EUSA Pharma and Roche for speaking at educational activities and research funding from AstraZeneca and is an inventor on 2 patents filed by the National Institutes of Health, National Cancer Institute: \u201cMethods for selecting and treating lymphoma types,\u201d licensed to NanoString Technologies, and \u201cEvaluation of MCL and methods related thereof\u201d, not related to this project. F.N. and E.C. licensed the use of the protected IgCaller algorithm for Diagn\u00f3stica Longwood. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethic Committee of the Hospital Clinic of Barcelona (HCB\/2021\/1076). Patients had given the informed consent for large scale genomic studies and the use of their samples for research purposes. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"166"}}